HSP90AB1 and neoplasm: Several studies demonstrated that HSP90β complexes in tumor cells have much higher affinity for ATP and HSP90β inhibitors when compared to those in normal cells, therefore suggesting the therapeutic potential of HSP90β inhibitors for killing cancer cells due to their high selectivity [11–13].